LEARNING OBJECTIVES

At the end of this educational activity, participants should be able:

1. To describe the global burden of cancer, including country and regional differences while comparing and contrasting the cancer burden in different regions in the world vs Sub-Saharan Africa
2. To understand the importance of cancer surveillance and the role of cancer registries to determine the burden and distribution of cancer in different regions and populations.
3. Understand the importance of multidisciplinary approaches to cancer prevention and the role of the National Cancer Control Programs/ National Cancer Institutes in Cancer Prevention. Participants should also be able to Articulate the role and contribution of different disciplines to cancer prevention and control
4. To describe the role of key lifestyle factors in the etiology of cancer, as well as approaches to cancer prevention.
5. To understand the role that occupational and environmental exposures play in the etiology of certain cancers, as well as preventive measures.
6. To understand the principles of clinical cancer prevention with a special emphasis on chemoprevention and future directions in the field.
7. To describe the cancer epidemiology and interpret current information on the descriptive epidemiology, etiology, screening, and early detection of some of the major cancers, as well as identify and adapt early detection methods for site-specific tumors.
8. Assess the strengths and weaknesses of the three main approaches to cancer prevention (primary, secondary, and tertiary) in general, and then relative to a specific country setting
9. Categorize advantages and disadvantages of all the current cancer screening methods
10. Discuss approaches and methods that can be used to adapt existing U.S. guidelines and evidence-based approaches in cancer prevention and control to different countries/settings
11. To design and present a primary prevention case study working in a multidisciplinary team. Participants will also be able to list key concepts critical to designing a basic implementation and/or dissemination science project. Finally, participants will be able to describe health communication tools in cancer prevention and control that target various stakeholders.
12. To be able to describe a low-budget approach to improve screening among disadvantaged and/or hard-to-reach communities.

Disclosure of Conflicts of Interest

International Cancer Institute (ICI) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ICI for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty must report any financial relationships or contractual relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Method of Participation and Request for Credit

To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures, and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.

THE COURSE LECTURES & DISCUSSIONS

Orientation to the course 

All those interested in registering for this course, please register your information on www.elearning.intercancer.com  if you have any questions or queries please send an email to education@intercancer.com or director@intercancer.com

For more information visit our website www.intercancer.com

International Cancer Institute (ICI) ©2022

Your Partner in Cancer Control in SSA